| wsnewspublishers In addition, the Company will issue to the investors warrants to purchase 625,000 shares of common stock. The warrants have an exercise price of $10.00 per share and are exercisable for 30 months from the closing date. The offering is predictable to … Biotech Top gainers : PlasmaTech Biopharmaceuticals, Inc. (NASDAQ:PTBI …StreetWise Report Stocks In Focus: Prologis, Inc. (NYSE:PLD), PlasmaTech Biopharmaceuticals …eMarketsDaily |
